Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history.

(Dado Ruvic/Reuters)

mRNA helped end the pandemic. Now it shows promise against skin cancer.

 What to know

An experimental mRNA drug, intismeran autogene, showed promise in treating aggressive skin cancer, according to a clinical trial. Developed by Moderna and Merck, it reduced the risk of recurrence or death by nearly half when combined with Keytruda. The trial involved 157 melanoma patients. Moderna reported consistent safety results, with common side effects including fatigue and injection site pain.

Summary is AI-generated, newsroom-reviewed.

Join the conversation

What are your thoughts on the potential of mRNA technology being used to treat aggressive skin cancer, as highlighted in the article?

Have a question? Ask the Post AI to learn more